HIV Subspecialty Care in Correctional Facilities Using Telemedicine

Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care
Jeremy D Young, Mahesh C Patel

Abstract

In the United States, prisons and jails contain a population at high risk for HIV infection with a relatively large proportion known to be HIV positive. However, many incarcerated persons lack access to subspecialty HIV care due to barriers of geography and travel. Telemedicine clinics can remove these barriers, increasing access to expert, multidisciplinary care. With telemedicine, correctional facilities can provide up-to-date, evidence-based HIV management, which may lead to improved compliance, greater virologic suppression, improved CD4 T-cell counts, fewer adverse drug interactions, and decreased transmission in the community. While HIV care in prisons is an example of harnessing this technology, telemedicine can be used for the diagnosis and management of multiple acute and chronic diseases for underserved populations.

References

Mar 14, 1996·The New England Journal of Medicine·M M KitahataE H Wagner
Apr 1, 1996·Telemedicine Journal : the Official Journal of the American Telemedicine Association·R M BrechtB Youngblood
Jun 26, 2001·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·D G EllisG J Pierluisi
Sep 29, 2001·Journal of Telemedicine and Telecare·C ZaylorD J Cook
Jul 1, 2004·American Journal of Public Health·Mardge H CohenTracey E Wilson
Jul 29, 2004·JAMA : the Journal of the American Medical Association·Ben G Raimer, John D Stobo
Jul 29, 2004·JAMA : the Journal of the American Medical Association·Newton E Kendig
Dec 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kelly A GeboUNKNOWN HIV Research Network
May 25, 2005·Archives of Internal Medicine·Bruce E LandonPaul D Cleary
Jun 1, 2006·American Journal of Public Health·Laura RosenDavid Zucker
Jun 9, 2006·International Journal of Medical Informatics·Cesar CaceresFrancisco del Pozo
Jul 31, 2007·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Karen C FoxTeresa M Waters
Oct 31, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeanne C Keruly, Richard D Moore
Nov 1, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Brian Wells PenceMichael J Mugavero
Jun 24, 2008·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Vladimir LavrentyevRonald C Merrell
Feb 17, 2009·American Journal of Public Health·Girma WoldemichaelNanette Benbow
Feb 18, 2009·The Journal of Infectious Diseases·Diana C LemlyStephen P Raffanti
Apr 3, 2009·The New England Journal of Medicine·Mari M KitahataUNKNOWN NA-ACCORD Investigators
Mar 10, 2011·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Brian GradyUNKNOWN American Telemedicine Association Telemental Health Standards and Guidelines Working Group
Jun 3, 2011·The New England Journal of Medicine·Sanjeev AroraClifford Qualls
Jun 3, 2011·The New England Journal of Medicine·Josiah D RichSamuel L Dickman
Jul 20, 2011·The New England Journal of Medicine·Myron S CohenUNKNOWN HPTN 052 Study Team
Apr 12, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeremy D YoungLawrence J Ouellet

❮ Previous
Next ❯

Citations

Oct 12, 2015·Current HIV/AIDS Reports·Kate JongbloedRichard T Lester

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved